Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?
TheFly reported on May 27 that IRWD reported that the U.S.
Ironwood Pharmaceuticals Inc (IRWD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Armistice Capital Steven Boyd | 15,028,000 | $52,748,280 | -7% | 0.94% |
| 2. | 46,942,000 | $46,120,515 | 1.49% | ||
| 3. | Sarissa Capital Management Alex Denner | 9,188,635 | $32,252,109 | -43% | 20.46% |
| 4. | 29,150,000 | $28,749,916 | +151% | 0.02% | |
| 5. | Renaissance Technologies Jim Simons | 8,061,073 | $28,294,366 | -2% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.70 | 6,920 | $60,204.00 | 121,028 | 2024-03-06 | Filing | |
| $9.38 | 10,684 | $100,215.92 | 301,733 | 2024-03-04 | Filing | |
| $8.32 | 36,072 | $300,119.04 | 188,730 | 2023-09-15 | Filing | |
| $10.54 | 75,000 | $790,500.00 | 16,390,000 | 2021-03-10 | Filing | |
| $10.30 | 150,000 | $1,545,000.00 | 16,315,000 | 2021-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.31 | 5,800 | $19,198.00 | 9,188,635 | 2026-03-17 | Filing | |
| $3.05 | 6,725,000 | $20,511,250.00 | 9,194,435 | 2026-03-17 | Filing | |
| $3.66 | 19,053 | $69,733.98 | 363,886 | 2026-02-24 | Filing | |
| $3.81 | 17,439 | $66,442.59 | 382,939 | 2026-02-23 | Filing | |
| $3.66 | 17,012 | $62,263.92 | 521,425 | 2026-02-24 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 59,619,000 | $58,113,620 | 1.34% | |
| 2. | 13,362,930 | $46,903,884 | 0% | |
| 3. | Ubs Group AgCALL | 11,200,320 | $39,313,123 | 0.01% |
| 4. | 8,682,907 | $30,477,004 | 0% | |
| 5. | 7,456,944 | $26,173,873 | 0% |
News See All
11 Most Undervalued Pharma Stocks to Invest In
Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he is confident about global stocks despite worries over the Iran war.
Is Ironwood Pharmaceuticals, Inc. (IRWD) a Comeback Pharma Stock After Major Earnings Improvement?
TheFly reported on May 7 that IRWD reported its first-quarter 2026 financial performance for the period ended March 31, 2026, showing great year-over-year improvement.
8 Best Small Cap Pharma Stocks to Buy Right Now
Despite the concerns surrounding the Iran War, Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he was optimistic about global stocks.
7 Best Small-Cap Drug Manufacturing Stocks to Buy According to Hedge Funds
In this article, we will take a look at some of the small-cap drug manufacturing stocks that are highly favored by hedge funds.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2025 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2025 Earnings Call Transcript February 25, 2026Ironwood Pharmaceuticals, Inc. misses on earnings expectations.
Craig-Hallum Bullish on Ironwood Pharmaceuticals (IRWD), Keeps Buy Rating
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is one of the cheap hot stocks to invest in right now.
11 Cheap Hot Stocks to Invest In Right Now
On January 23, Ryan Detrick, Carson Group chief market strategist, appeared on CNBC's 'Squawk Box' to discuss the latest market trends and the outlook for 2026.
Ironwood (IRWD) Skyrockets 23% as Govt Price for Linzess Falls Within Expectations
Ironwood Pharmaceuticals soared by 23.32 percent on Wednesday to end at $3.86 apiece as investors cheered the new price set by the Health Department for its bowel treatment, which fell in line with its...
12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical ...